Figure 2From: The laminin β1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma Topical treatment of the airways with YIGSR increases ASM contractility and contractile protein accumulation. (A) Treatment with YIGSR enhanced the maximal methacholine-induced isometric contraction of epithelium-denuded tracheal smooth muscle preparations both in saline- and in ovalbumin-challenged animals. (B) Treatment with YIGSR increased pulmonary expression of sm-MHC, both in saline- and in ovalbumin-challenged animals. Representative blots of sm-MHC and β-actin are shown. ***P < 0.001 compared to saline-treated, saline-challenged controls. ##P < 0.01 compared to saline-treated, ovalbumin-challenged controls. Data represent means ± SEM of 5-7 animals.Back to article page